Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: Results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial
Patrick Kwan, Eugen Trinka, Wim Van Paesschen, Ivan Rektor, Martin E Johnson, Sarah Lu
Epilepsia | WILEY | Published : 2014
The authors thank the patients and members of the N01254 Study Group for their participation and contributions to the study, and Laurent Turet PhD (UCB Pharma, Brussels, Belgium) for critical review of this manuscript and coordination of manuscript preparation. Sally Cotterill PhD (QXV Communications, Macclesfield, United Kingdom) provided editorial support, which was funded by UCB Pharma.